Cargando…
Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach
BACKGROUND AND OBJECTIVE: Human epidermal growth factor receptor 2 (HER2) protein overexpression is one of the most significant biomarkers for breast cancer diagnostics, treatment prediction, and prognostics. The high accessibility of HER2 inhibitors in routine clinical practice directly translates...
Autores principales: | Wojtaszewska, Marzena, Stępień, Rafał, Woźna, Alicja, Piernik, Maciej, Sztromwasser, Pawel, Dąbrowski, Maciej, Gniot, Michał, Szymański, Sławomir, Socha, Maciej, Kasprzak, Piotr, Matkowski, Rafał, Zawadzki, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766398/ https://www.ncbi.nlm.nih.gov/pubmed/34932189 http://dx.doi.org/10.1007/s40291-021-00571-1 |
Ejemplares similares
-
The cancer-risk variant frequency among Polish population reported by the first national whole-genome sequencing study
por: Mroczek, Magdalena, et al.
Publicado: (2023) -
The Thousand Polish Genomes—A Database of Polish Variant Allele Frequencies
por: Kaja, Elżbieta, et al.
Publicado: (2022) -
Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up
por: Donizy, Piotr, et al.
Publicado: (2016) -
Identification of stable, high copy number, medium-sized RNA degradation intermediates that accumulate in plants under non-stress conditions
por: Nowacka, Martyna, et al.
Publicado: (2013) -
Gene Variants Related to Cardiovascular and Pulmonary Diseases May Correlate with Severe Outcome of COVID-19
por: Sypniewski, Mateusz, et al.
Publicado: (2022)